Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 11 | $0.34 | $0.37 | $0.35 |
| Q2 2026 | 10 | $0.25 | $0.31 | $0.27 |
| Q3 2026 | 9 | $0.18 | $0.21 | $0.20 |
| Q4 2026 | 7 | $0.19 | $0.20 | $0.20 |
| Q1 2027 | 3 | $0.39 | $0.40 | $0.40 |
| Q2 2027 | 3 | $0.31 | $0.32 | $0.31 |
| Q3 2027 | 4 | $0.22 | $0.23 | $0.22 |
| Q4 2027 | 3 | $0.22 | $0.22 | $0.22 |
| Q1 2028 | 4 | $0.43 | $0.45 | $0.44 |
| Q2 2028 | 4 | $0.35 | $0.36 | $0.35 |
| Q3 2028 | 6 | $0.25 | $0.26 | $0.26 |
| Q4 2028 | 4 | $0.25 | $0.26 | $0.25 |
Elanco Animal Health Inc last posted its earnings results on Wednesday, May 6th, 2026. The company reported $0.4 earnings per share for the quarter, topping analysts' consensus estimates of $0.34 by $0.06. The company had revenue of 1.37 B for the quarter and had revenue of 4.72 B for the year. Elanco Animal Health Inc has generated $0 earnings per share over the last year ($-0.47 diluted earnings per share) and currently has a price-to-earnings ratio of -44.83. Elanco Animal Health Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2026 | Q1 2026 | $0.34 | $0.11 | -0.23 | $1.28 B | $1.37 B |
| 02/24/2026 | Q4 2025 | $0.11 | -$0.56 | -0.67 | $1.09 B | $1.14 B |
| 11/05/2025 | Q3 2025 | $0.13 | -$0.07 | -0.2 | $1.09 B | $1.14 B |
| 08/07/2025 | Q2 2025 | $0.20 | $0.02 | -0.18 | $1.19 B | $1.24 B |
| 05/07/2025 | Q1 2025 | $0.31 | $0.14 | -0.17 | $1.17 B | $1.19 B |
| 02/25/2025 | Q4 2024 | $0.16 | -$0.02 | -0.18 | $1.01 B | $1.02 B |
| 11/07/2024 | Q3 2024 | $0.12 | $0.74 | 0.62 | $1.04 B | $1.03 B |
| 08/08/2024 | Q2 2024 | $0.24 | -$0.10 | -0.34 | $1.15 B | $1.18 B |
| 05/08/2024 | Q1 2024 | $0.27 | $0.06 | -0.21 | $1.19 B | $1.21 B |
| 02/26/2024 | Q4 2023 | $0.10 | -$0.29 | -0.39 | N/A | $1.04 B |
| 11/07/2023 | Q3 2023 | $0.12 | -$2.22 | -2.34 | N/A | $1.07 B |
| 08/07/2023 | Q2 2023 | $0.05 | -$0.20 | -0.25 | N/A | $1.06 B |
| 05/09/2023 | Q1 2023 | $0.29 | $0.21 | -0.08 | N/A | $1.26 B |
| 03/01/2023 | Q4 2022 | N/A | -$0.11 | N/A | N/A | $988.00 M |
| 11/08/2022 | Q3 2022 | $0.16 | -$0.13 | -0.29 | N/A | $1.03 B |
| 08/08/2022 | Q2 2022 | $0.26 | -$0.02 | -0.28 | N/A | $1.18 B |
| 05/09/2022 | Q1 2022 | $0.35 | $0.10 | -0.25 | N/A | $1.23 B |
| 02/28/2022 | Q4 2021 | N/A | -$0.20 | N/A | N/A | $1.11 B |
| 11/05/2021 | Q3 2021 | $0.17 | -$0.21 | -0.38 | N/A | $1.13 B |
| 08/09/2021 | Q2 2021 | $0.26 | -$0.43 | -0.69 | N/A | $1.28 B |
In the previous quarter, Elanco Animal Health Inc (:ELAN) reported $0.4 earnings per share (EPS) to beat the analysts' consensus estimate of $0.34 by $0.06.
The conference call for Elanco Animal Health Inc's latest earnings report can be listened to online.
The conference call transcript for Elanco Animal Health Inc's latest earnings report can be read online.
Elanco Animal Health Inc (:ELAN) has a recorded annual revenue of $4.72 B.
Elanco Animal Health Inc (:ELAN) has a recorded net income of $-232,000,000.Elanco Animal Health Inc has generated $-0.47 earnings per share over the last four quarters.
Elanco Animal Health Inc (:ELAN) has a price-to-earnings ratio of -44.83 and price/earnings-to-growth ratio is 0.28.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED